New molecular targets for the treatment of osteoarthritis

MJ Alcaraz, J Megías, I García-Arnandis… - Biochemical …, 2010 - Elsevier
Osteoarthritis (OA) is a chronic degenerative joint disorder characterized by destruction of
the articular cartilage, subchondral bone alterations and synovitis. Current treatments are …

Recent advances in the understanding of molecular mechanisms of cartilage degeneration, synovitis and subchondral bone changes in osteoarthritis

Y Wei, L Bai - Connective tissue research, 2016 - Taylor & Francis
Osteoarthritis (OA), the most common form of degenerative joint disease, is linked to high
morbidity. It is predicted to be the single greatest cause of disability in the general population …

[PDF][PDF] Future directions for research and treatment of osteoarthritis

CJ Malemud, VM Goldberg - Front Biosci, 1999 - article.imrpress.com
[Frontiers in Bioscience 4, d762-771, October 15, 1999] 762 FUTURE DIRECTIONS FOR
RESEARCH AND TREATMENT OF OSTEOARTHRITIS Charl Page 1 [Frontiers in Bioscience 4 …

Therapeutics in osteoarthritis based on an understanding of its molecular pathogenesis

JR Kim, JJ Yoo, HA Kim - International journal of molecular sciences, 2018 - mdpi.com
Osteoarthritis (OA) is the most prevalent joint disease in older people and is characterized
by the progressive destruction of articular cartilage, synovial inflammation, changes in …

Osteoarthritis: novel molecular mechanisms increase our understanding of the disease pathology

S Grässel, F Zaucke, H Madry - Journal of clinical medicine, 2021 - mdpi.com
Although osteoarthritis (OA) is the most common musculoskeletal condition that causes
significant health and social problems worldwide, its exact etiology is still unclear. With an …

[HTML][HTML] Osteoarthritis year in review 2014: genetics and genomics

A Tsezou - Osteoarthritis and cartilage, 2014 - Elsevier
Recent developments in genetics/genomics of osteoarthritis (OA) are discussed to improve
our understanding of OA pathophysiology. The discovery of a novel variant near the NCOA3 …

Emerging targets in osteoarthritis therapy

MB Goldring, F Berenbaum - Current opinion in pharmacology, 2015 - Elsevier
Highlights•Different OA etiologies present a challenge for developing a single targeted
therapy.•Common mechanisms occur in inflammatory, mechanical, and oxidative stress in …

Osteoarthritis: a narrative review of molecular approaches to disease management

LA Salman, G Ahmed, SG Dakin, B Kendrick… - Arthritis Research & …, 2023 - Springer
Osteoarthritis (OA) is a chronic, progressive degenerative whole joint disease that affects the
articular cartilage, subchondral bone, ligaments, capsule, and synovium. While it is still …

New findings in osteoarthritis pathogenesis: therapeutic implications

L Pulsatelli, O Addimanda, V Brusi… - … in Chronic Disease, 2013 - journals.sagepub.com
This review focuses on the new perspectives which can provide insight into the crucial
pathways that drive cartilage-bone physiopathology. In particular, we discuss the critical …

Emerging therapeutic agents in osteoarthritis

MJ Alcaraz, MI Guillén, ML Ferrándiz - Biochemical Pharmacology, 2019 - Elsevier
Osteoarthritis (OA) is the most common joint disorder and a leading cause of disability.
Current treatments for OA can improve symptoms but do not delay the progression of …